practice

Cyprus IVF Gender Selection

A Medical Option to Prevent Inherited Diseases – Not a Lifestyle Choice

When people hear “gender selection in Cyprus,” many immediately think of parents simply choosing a boy or a girl.
In reality, Cyprus IVF gender selection is strictly framed as a medical tool, used to prevent serious inherited conditions linked to sex chromosomes – not to satisfy personal preferences.

This article explains:

  • When and why gender selection is considered in Cyprus

  • Which sex-linked genetic conditions are involved

  • How the process is integrated into IVF and genetic testing

  • Why this practice is viewed as a protective medical option rather than a cosmetic choice


Legal and Ethical Framework in Cyprus

In Cyprus, assisted reproduction is regulated by clear rules. One of the core principles is:

Gender selection for purely social or “family balancing” reasons is not permitted.

In practice, this means that requests such as:

  • “We already have a boy, now we want a girl”

  • “Our family prefers sons or daughters”

are not accepted as valid reasons for gender selection.

By contrast, gender selection for medical indications can be considered in cases such as:

  • Families with known sex-linked genetic diseases

  • Couples who already have a child affected by a sex chromosome disorder

  • Situations where a serious inherited condition manifests far more severely in one sex

In these cases, the goal is not simply to choose a preferred sex, but to reduce the risk that a child will be born with a severe, sex-linked genetic disorder.


Sex Chromosome Disorders: The Medical Background

Sex chromosome disorders arise from numerical or structural abnormalities of the X or Y chromosomes.
They can affect:

  • Physical growth and development

  • Hormonal balance and fertility

  • Cognitive abilities and learning

  • Overall health and quality of life

Below are some key examples.

Turner Syndrome (45,X)

  • Occurs when one X chromosome is missing or structurally abnormal.

  • Affects phenotypic females.

  • Typical features include short stature, ovarian insufficiency, infertility and an increased risk of certain heart and vascular problems.

Klinefelter Syndrome (47,XXY)

  • Caused by an extra X chromosome in males (XXY instead of XY).

  • Often associated with low testosterone, small testes, reduced sperm production or infertility.

  • May be accompanied by learning difficulties and behavioural challenges.

Triple X Syndrome (47,XXX)

  • Involves an extra X chromosome in females.

  • Many individuals have mild or minimal symptoms.

  • Some may experience learning difficulties, attention problems and subtle differences in motor or musculoskeletal development.

XYY Syndrome (47,XYY)

  • Results from an extra Y chromosome in males.

  • Frequently associated with taller than average height.

  • Some may have learning or behavioural problems.

Fragile X Syndrome

  • Linked to a fragile region on the X chromosome.

  • One of the most common inherited causes of intellectual disability.

  • Can be associated with developmental delay, learning difficulties, social and behavioural issues and autism spectrum features.

  • Families with a history of Fragile X require detailed genetic counselling and testing.

Y-Linked Traits and Conditions

The Y chromosome carries genes that are transmitted only from fathers to sons.
Some traits and rare conditions linked to the Y chromosome – such as certain patterns of hair growth or congenital anomalies – occur only in males.

All of these examples highlight an important point:
in some families, the combination of a specific gene and a specific sex can dramatically change the severity and expression of a disease.


Why Gender Can Be Medically Relevant

For many genetic conditions, the child’s sex is not just a detail – it can be central to how the disease appears.

  • Some disorders are X-linked, and they often affect males much more severely than females.

  • Females may be carriers with mild or no symptoms, while males have significant disability.

  • Certain sex chromosome anomalies, such as Turner or Klinefelter syndromes, are closely tied to XX or XY patterns.

In such families, selecting embryos that do not carry the disease and/or are of the safer sex can substantially reduce the risk of:

  • Severe intellectual disability

  • Lifelong dependency and complex care needs

  • Significant hormonal and reproductive problems

  • Recurrent pregnancy loss related to chromosomal abnormalities

For couples at risk of sex-linked conditions, gender selection combined with genetic testing becomes a protective medical strategy rather than a matter of preference.


How Cyprus IVF Programmes Integrate Gender Selection

In Cyprus, gender selection for medical reasons is not an isolated service.
It is integrated into a structured IVF and genetic testing pathway. The process typically includes these steps:

1. IVF / ICSI Treatment

  • The woman’s ovaries are stimulated to produce multiple eggs.

  • Mature eggs are collected and fertilised in the laboratory using partner or donor sperm.

  • Embryos are cultured for several days in controlled incubators.

2. Embryo Biopsy

  • Once embryos reach an appropriate developmental stage, a small number of cells is gently removed from each embryo.

  • The biopsy is performed with great care so as not to harm the embryo’s developmental potential.

  • The sampled cells are sent for detailed genetic analysis.

3. Genetic Testing (PGT)

  • Chromosomes are examined to detect numerical and structural abnormalities.

  • When there is a known family risk, specific sex-linked mutations are investigated.

  • The chromosomal sex of each embryo (XX or XY) is identified.

4. Selecting Medically Suitable Embryos

Based on the genetic results, the medical team can:

  • Exclude embryos that carry the targeted sex-linked disorder

  • Prioritise embryos that are chromosomally normal and do not show the disease in question

The aim is not to satisfy a wish for a particular sex,
but to transfer embryos that offer the best chance of a healthy child, free from the identified sex-linked condition.

5. Embryo Transfer

  • One or more of the selected healthy embryos are transferred to the uterus, in line with local regulations on the maximum number of embryos per transfer.

  • Pregnancy testing and follow-up continue as in a standard IVF cycle.


A Protective Measure, Not a Lifestyle Option

From the outside, gender selection can sound like a way to “customise” your family.
Within the legal and medical framework in Cyprus, the reality is very different:

  • The primary goal is to prevent severe genetic disease, not to design a family according to personal taste.

  • Every case is evaluated by fertility specialists and clinical geneticists.

  • The approach is offered only when there is a clear, documented medical indication.

This makes gender selection in Cyprus IVF:

  • A preventive medical measure

  • A way to reduce suffering linked to sex-linked disorders

  • A tool to break the cycle of serious inherited disease in affected families


Frequently Asked Questions

Is gender selection available to anyone who wants it in Cyprus?
No. It is not offered for casual reasons or simple family balancing.
It is considered only when there is a high risk of a sex-linked genetic condition and after thorough medical evaluation.

Does gender selection guarantee a completely healthy child?
No method can provide an absolute guarantee.
However, combining IVF, genetic testing and medically indicated gender selection can significantly reduce the risk of certain inherited disorders.

Who decides whether gender selection is appropriate?
The decision is made jointly by fertility specialists, clinical geneticists and the couple, after reviewing the family history, genetic tests and available medical evidence.

Is gender selection mandatory if there is a risk?
No. It is an option offered to families in a defined risk group.
The final decision is made by the couple after detailed counselling and informed consent.

  • Paylaş: